Easyspine Osteosynthesis System

A posterior osteosynthesis system called Easyspine and the BF+ complementary synthetic bone substitute comprised of highly biocompatible beta tri-calcium phosphate were developed in France by LDR Medical (Troyes). Both have now been cleared by the U.S. Food and Drug Adminstration (FDA).

Easyspine has been successfully used in more than 2, 200 procedures to date, notes the company. Its patent-pending pedicle screw design, with integrated multi-axial capability, provides flat-on-flat screw-to-rod purchase and can vary stiffness by accommodating rods of different thickness. This design approach provides many technical advantages and creates a system that offers the surgeon better intraoperative flexibility while using only one-third the inventory levels of conventional fusion systems. In addition, all LDR spine implant products are delivered to the hospital individually packaged, labeled, and sterilized.

In partnership with LDR Medical in Troyes, LDR Spine (Austin, TX, USA) serves as a distributor of the company's spine products in the United States. "We are excited by the success these products have experienced in Europe and are encouraged by the enthusiastic response we are getting from both surgeons and spine device distributors regarding all of our spinal product offerings,” commented Steve Whitelock, president and CEO of LDR Spine.




Related Links:
LDR Medical